Drug · DIN 02409623
MEKINIST
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 4, 2016; first marketed August 28, 2013.
- Drug Identification Number (DIN)
- 02409623
- Company (DIN owner)
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Trametinib L01EE01
- Class
- Human
- Record last updated
- March 2, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| TRAMETINIB | 0.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 31, 2015: NOC 17155New Drug Submission (NDS) · Transfer of Drug Identification Number(s)
- July 18, 2013: NOC 14557New Drug Submission (NDS)
Other DINs named MEKINIST
- DIN 02409658 · Marketed
- DIN 02539993 · Marketed
- DIN 02409631 · Cancelled Pre Market